ECT in the Treatment of Patients with Neurological and Somatic Disease

Zwil, Alexander S.; Pelchat, Rodney

doi:10.2190/5hxy-acm5-q6pk-04h5

Cited by 41 publications

(15 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…20 In our patient, after a failure to respond to these initial approaches, it was felt that to continue pursuing additional medical therapies would place him at an unacceptable risk of developing serious complications of malignant syndrome, including rhabdomyolysis, acute renal failure, disseminated intravascular coagulation and deep vein thrombosis. Given that ECT has been shown to be a safe and effective treatment in the medically ill, 8 in patients with PD 9 and in NMS, 10 we felt that ECT was the most appropriate treatment. In fact, Trollor and Sachdev 10 have argued that the response to ECT appears to be faster than to pharmacological treatment, although no direct comparison studies have been performed.…”

Section: Discussionmentioning

confidence: 99%

“…7 Electroconvulsive therapy (ECT) is recognised to be a safe and effective treatment for a range of affective and catatonic disorders in patients with neurological disorders. 8 Case reports have also indicated that ECT has therapeutic effects in patients with severe PD but without affective or psychotic disorders. 9 Multiple case reports have demonstrated the effectiveness of ECT in the treatment of NMS.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Parkinsonism–hyperpyrexia syndrome: The role of electroconvulsive therapy

Meagher

McKay

Herkes

et al. 2006

Journal of Clinical Neuroscience

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Parkinsonism–hyperpyrexia syndrome: The role of electroconvulsive therapy

Meagher

McKay

Herkes

et al. 2006

Journal of Clinical Neuroscience

View full text Add to dashboard Cite

“…Relaxation therapy, guided imagery, systematic desensitisation, problem solving, education and other supportive interventions (Level I) 15,16 Depressive symptoms Relaxation therapy, guided imagery, psycho-education, problem solving, and other supportive interventions (Level I) 15,16,[603][604][605] Note: Specialised interventions that can be conducted by appropriately qualified health professionals are outlined in Chapter 4.…”

Section: Anxietymentioning

confidence: 99%

“…ECT has demonstrated efficacy in the treatment of severe depression, and is generally well-tolerated even in those with concurrent medical conditions (Level I). [603][604][605]683 • Psychostimulants: Patients with advanced cancer may experience some improvement in depressed mood,appetite and well-being when treated with low-dose psychostimulants. 698 They are generally well-tolerated, and a particular benefit in terminally-ill patients is the rapid onset of action.…”

mentioning

confidence: 99%

Broken doctor–patient relationships: why won't they listen?

Jefford

Zalcberg

2014

Medical Journal of Australia

View full text Add to dashboard Cite

Every user of this rescinded publication acknowledges that the information contained in it may not be accurate, complete or of relevance to the user's purposes. The user undertakes the responsibility for assessing the accuracy, completeness and relevance of the contents of this rescinded publication, including seeking independent verification of information sought to be relied upon for the user's purposes.Every user of this rescinded publication is responsible for ensuring that each printed version contains this disclaimer notice, including the date of recision and the date of downloading the archived Internet version. This work is copyright.Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from National Breast Cancer Centre. Requests and enquiries concerning reproduction and rights should be addressed to the Copyright Office, National Breast Cancer Centre, Locked Bag 16, Camperdown NSW 1450, Australia.Website:www.nbcc.org.au Email: directorate@nbcc.org.au These guidelines were approved by the National Health and Medical Research Council at its 147th Session on 10 April 2003, under section 14A of the National Health and Medical Research Council Act 1992.Approval for the guidelines by NHMRC is granted for a period not exceeding five years, at which date the approval expires.The NHMRC expects that all guidelines will be reviewed no less than once every five years. Readers should check with the National Breast Cancer Centre for any reviews or updates of these guidelines. RESCINDEDThe strategic intent of the NHMRC is to provide leadership and work with other relevant organisations to improve the health of all Australians by:• fostering and supporting a high quality and internationally recognised research base; • providing evidence based advice; • applying research evidence to health issues thus translating research into better health practice and outcomes; and • promoting informed debate on health and medical research, health ethics and related issues.This document is a general guide to appropriate practice, to be followed subject to the clinician's judgement and the patient's preference in each individual case.The guidelines are designed to provide information to assist decision-making and are based on the best evidence available at the time of publication. C O N T E N T S L I S T O F TA B L E S L I S T O F F I G U R E S F O R E W O R DOptimal care of the patient with cancer incorporates effective physical and psychological care.There are currently several clinical practice guidelines available documenting evidence-based information and treatment recommendations for the physical care of people with cancer, many of which are also available in consumer versions. Some of these treatment guidelines include chapters devoted to psychosocial care.People with cancer suffer significant emotional morbidity. In addition to the distress, fear and grief consequent upon diagnosis, up to 30% experience clinically significant anxiety disorde...

show abstract

“…While therapeutic strategies against catatonia are proven to be successful in schizophrenic disorders less is known about their effect in catatonic syndromes caused by somatic disorders as in the following case (Tandon et al 1988;Zwil and Pelchat 1994).…”

Section: Introductionmentioning

confidence: 99%

Therapeutic strategies for catatonia in paraneoplastic encephalitis

Kaestner

Mostert

Behnken

et al. 2008

The World Journal of Biological Psychiatry

View full text Add to dashboard Cite

This report is about a 40-year-old man suffering from fluctuating catatonia as main symptom of long-lasting paraneoplastic encephalitis caused by a testicular neoplasm. With recurrence of a neoplasm initially diagnosed as seminoma after a 7-year symptom-free interval the patient suddenly developed various neurological and psychopathological symptoms including seizures, autonomic dysregulation, continuous anterograde short-term amnesia and predominantly a long-lasting complex catatonic syndrome with on-off phenomena. Repeated MRI scans of the brain showed no pathology; brain FDG-PET scans indicated a hypometabolism of the frontal cortex and the left temporal lobe. Eventually a paraneoplastic encephalitis was diagnosed. Repeated resections of tumour recurrences and plasmapheresis moderately alleviated catatonic symptoms. Haloperidol and lorazepam effectively relieved catatonic symptoms in contrast to various atypical antipsychotic drugs and diazepam. A series of 12 electroconvulsive treatments (ECT) temporarily improved residual catatonic symptoms such as catalepsy, stupor and mutism. Further neoplasm recurrences, however, reinforced catatonia until the tumour was successfully treated and the patient fully recovered. This case report illustrates the potential but also the limitations of various therapeutic approaches in organic catatonia due to paraneoplastic encephalitis.

show abstract

ECT in the Treatment of Patients with Neurological and Somatic Disease

Cited by 41 publications

References 76 publications

Parkinsonism–hyperpyrexia syndrome: The role of electroconvulsive therapy

Parkinsonism–hyperpyrexia syndrome: The role of electroconvulsive therapy

Broken doctor–patient relationships: why won't they listen?

Therapeutic strategies for catatonia in paraneoplastic encephalitis

Contact Info

Product

Resources

About